Interview Series 20th March 2026
From the helm: Clarity Pharma (ASX:CU6), Chair, Alan Taylor & Senior Bell Potter Analyst John Hester
In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.





_600_338.jpg)


-min_600_399.png)
-min_600_338.png)
_600_338.png)
